KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Research & Development: 2009-2025

Historic Research & Development for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $346.0 million.

  • Thermo Fisher Scientific's Research & Development changed negligibly% to $346.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 5.29%. This contributed to the annual value of $1.4 billion for FY2024, which is 3.96% up from last year.
  • Thermo Fisher Scientific's Research & Development amounted to $346.0 million in Q3 2025, which was down 1.70% from $352.0 million recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Research & Development high stood at $392.0 million for Q4 2021, and its period low was $319.0 million during Q3 2023.
  • Its 3-year average for Research & Development is $342.5 million, with a median of $345.0 million in 2023.
  • Per our database at Business Quant, Thermo Fisher Scientific's Research & Development surged by 30.61% in 2021 and then dropped by 16.37% in 2023.
  • Thermo Fisher Scientific's Research & Development (Quarterly) stood at $392.0 million in 2021, then fell by 0.26% to $391.0 million in 2022, then declined by 16.37% to $327.0 million in 2023, then climbed by 14.37% to $374.0 million in 2024, then remained steady at $346.0 million in 2025.
  • Its Research & Development was $346.0 million in Q3 2025, compared to $352.0 million in Q2 2025 and $342.0 million in Q1 2025.